Cancer Stem Cells - Therapeutic Boon!

Shrihari, T. G.
November 2011
Journal of Cancer Science & Therapy;2011, Vol. 3 Issue 8, p197
Academic Journal
Cancer stem cells (CSC) are recently proposed to be the cancer initiating cells responsible for tumorigenesis and contribute to cancer resistance. Like normal stem cells, cancer stem cells should be rare, quiescent and capable of self renewing & maintaining tumor growth and heterogeneity. Although the concept of cancer stem cells originates from that of normal stem cells, cancer stem cells are not necessarily aberrant counterparts of normal stem cells. In fact, they may arise from stem cells or committed progenitors of corresponding tissues & even cells from other tissues. At the molecular level, the alteration of stem cell self-renewal pathways has been recognized as an essential step for cancer stem cells transformation. Better understanding of cancer stem cell will no doubt lead to new era of both basic & clinical research, reclassification of human tumors & development of novel therapeutic strategies specifically targeting cancer stem cells.


Related Articles

  • Side-population Cells Derived from Non-tumorigenic Rat Endometrial Cells are a Candidate Cell of Origin for Malignant Endometrial Tumors. Kato, Kiyoko; Kusunoki, Soshi; Inagaki, Tetsunori; Yusuf, Nurisimangul; Okabe, Hitomi; Suga, Shin; Kaneda, Hiroshi; Terao, Yasuhisa; Arima, Takahiro; Tsukimori, Kiyomi; Takeda, Satoru // Journal of Stem Cell Research & Therapy;Special2012, Vol. 2 Issue S, Special section p1 

    We have previously demonstrated that side population (SP) cells derived from endometrial cancer cells have cancer stem-like cell features. However, the role of stem cell-enriched subpopulations, SP cells in normal endometrium for carcinogenesis is still poorly understood. In the present study,...

  • The Dynamics and Prognostic Potential of DNA Methylation Changes at Stem Cell Gene Loci in Women's Cancer. Zhuang, Joanna; Jones, Allison; Shih-Han Lee; Ng, Esther; Fiegl, Heidi; Zikan, Michal; Cibula, David; Sargent, Alexandra; Salvesen, Helga B.; Jacobs, Ian J.; Kitchener, Henry C.; Teschendorff, Andrew E.; Widschwendter, Martin // PLoS Genetics;Feb2012, Vol. 8 Issue 2, Special section p1 

    Aberrant DNA methylation is an important cancer hallmark, yet the dynamics of DNA methylation changes in human carcinogenesis remain largely unexplored. Moreover, the role of DNA methylation for prediction of clinical outcome is still uncertain and confined to specific cancers. Here we perform...

  • Understanding cancer stem cell heterogeneity and plasticity. Tang, Dean G // Cell Research;Mar2012, Vol. 22 Issue 3, p457 

    Heterogeneity is an omnipresent feature of mammalian cells in vitro and in vivo. It has been recently realized that even mouse and human embryonic stem cells under the best culture conditions are heterogeneous containing pluripotent as well as partially committed cells. Somatic stem cells in...

  • Cancer stem cells: Upping the stemness during tumour progression. Alderton, Gemma K. // Nature Reviews Cancer;Jan2013, Vol. 13 Issue 1, p7 

    The article reports that there are some cancer stem cells (CSCs) that grows rapidly and their number changes with the increase in squamous skin tumours.

  • Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy. Leirós, G. J.; Balañá, M. E. // Current Pharmaceutical Biotechnology;Nov2011, Vol. 12 Issue 11, p1909 

    The cancer stem cell (CSC) hypothesis, predicts that a small subpopulation of cancer cells that possess "stem-like" characteristics, are responsible for initiating and maintaining cancer growth. According to the CSC model the many cell populations found in a tumour might represent diverse stages...

  • Cancer Stem Cells: Getting to the Root of Cancer. Azvolinsky, Anna // JNCI: Journal of the National Cancer Institute;Jun2012, Vol. 104 Issue 12, p893 

    The article discusses the cancer stem cell (CSC) theory which states that only CSCs drive tumorigenesis and cancer cannot be cured without eradicating the CSCs that drive it. Proponents of this theory believe that it can lead to next-generation therapies that target core cancer-producing cells...

  • Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century. Williams, Samuel A; Anderson, Wade C; Santaguida, Marianne T; Dylla, Scott J // Laboratory Investigation (00236837);Sep2013, Vol. 93 Issue 9, p970 

    Cancer is a heterogeneous disease manifest in many forms. Tumor histopathology can differ significantly among patients and cellular heterogeneity within tumors is common. A primary goal of cancer biologists is to better understand tumorigenesis and cancer progression; however, the complex nature...

  • Molecular heterogeneity in adjacent cells in triple-negative breast cancer. Huebschman, Michael L.; Lane, Nancy L.; Huaying Liu; Sarode, Venetia R.; Devlin, Judith L.; Frenkel, Eugene P. // Breast Cancer: Targets & Therapy;Aug2015, Vol. 7, p231 

    Purpose: This study interrogates the molecular status of individual cells in patients with triple-negative breast cancers and explores the molecular identification and characterization of these tumors to consider the exploitation of a potential-targeted therapeutic approach. Patients and...

  • Chemically-Induced Cancers Do Not Originate from Bone Marrow-Derived Cells. Hui Lin; Liang Hu; Leilei Chen; Hong Yu; Qi Wang; Ping Chen; Xiao-Tong Hu; Xiu-Jun Cai; Xin-Yuan Guan // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Background: The identification and characterization of cancer stem cells (CSCs) is imperative to understanding the mechanism of cancer pathogenesis. Growing evidence suggests that CSCs play critical roles in the development and progression of cancer. However, controversy exists as to whether...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics